Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

BACKGROUND: Fluticasone furoate (FF) is a novel long-acting inhaled corticosteroid (ICS). This double-blind, placebo-controlled randomized study evaluated the efficacy and safety of FF 200 mcg or 400 mcg once daily, either in the morning or in the evening, and FF 200 mcg twice daily (morning and eve...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Woodcock, Ashley, Bateman, Eric D, Busse, William W, Lötvall, Jan, Snowise, Neil G, Forth, Richard, Jacques, Loretta, Haumann, Brett, Bleecker, Eugene R
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2011
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3217852/
https://ncbi.nlm.nih.gov/pubmed/21977941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-12-132
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items